← Leaderboards
Neil Malhotra
University Of Pennsylvania
$1,511,796
Attributed
$4,139,107
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,139,107 · 5
By mechanism
R01$2,717,504 · 1
R21$1,421,603 · 4
Top collaborators
- Lachlan James Smith9 shared
- Robert Leon Mauck5 shared
- Roderic G Eckenhoff2 shared
- W Andrew Kofke1 shared
- Paul Regier1 shared
- Gebhard Wagener1 shared
- Robert A Whittington1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Irving M Shapiro$13,291,729
- Douglas J Epstein$22,307,735
- Lachlan James Smith$3,508,362
- Deborah J Culley$6,423,070
- Michael Granato$25,456,465
Others in their field
Other Emerging Leaders on “Inflammation”
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Jacob D Estes · Oregon Health & Science University$13,447,606
- Bradley G Hammill · Duke University$13,296,940
- James Dale Berry · Brigham And Women'S Hospital$11,004,714
- Gary Fanger · Rise Therapeutics, Llc$10,261,718
- Barbara Halina Braffett · George Washington University$9,972,097
Research focus
InflammationStructureMediatingInflammatoryPre-ClinicalLow Back PainDisc RegenerationNucleus PulposusTissuesNovel TherapeuticsIntervertebral Disk DegenerationIn VivoStem CellsCellsMechanicsIntervertebral Disc StructureSeveritiesBiomechanicsCharacteristicsPositioning AttributeBiological Response Modifier TherapyPharmaceutical PreparationsDosePain Patient
Grant awards (12)
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$500,264
R01 · FY2025 · AR
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$546,109
R01 · FY2024 · AR
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$537,934
R01 · FY2023 · AR
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$545,884
R01 · FY2022 · AR
Prescribed opioid induced brain damage in chronic pain patients$203,125
R21 · FY2022 · DA
Dynamic heterogeneity of nucleus pulposus cells from development to degeneration$176,963
R21 · FY2022 · AR
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells$587,313
R01 · FY2021 · AR
Relationship between CNS Tau burden and perioperative neurocognitive disorder$219,248
R21 · FY2021 · AG
Dynamic heterogeneity of nucleus pulposus cells from development to degeneration$214,390
R21 · FY2021 · AR
Relationship between CNS Tau burden and perioperative neurocognitive disorder$206,668
R21 · FY2020 · AG
Regenerative potential of embryonic notochordal nucleus pulposus progenitors$181,821
R21 · FY2018 · AR
Regenerative potential of embryonic notochordal nucleus pulposus progenitors$219,388
R21 · FY2017 · AR